Multiple Sclerosis Biosimilars in the United States: How to

Multiple Sclerosis Biosimilars in the United States: How to Communicate With Your Patient for Successful Implementation

Listen now

Description

Do you know how to have a heads-up conversation about biosimilars? Credit available for this activity expires: 6/6/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001162?ecd=bdc_podcast_libsyn_mscpedu

More Episodes

See all »

Back to Basics in Agitation Associated With Alzheimer's Disease: Mechanisms and Implications for Treatment

Did you know agitation is a treatable entity among patients with Alzheimer’s disease? Learn about potential causes and treatments for agitation. Credit available for this activity expires: 10/29/25 Earn Credit / Learning Objectives & Disclosures:...

Published 10/29/24

Keeping Current CME

Published 10/29/24

Expert Roundtable on the Use of Anti-Amyloid Therapies for the Treatment of Alzheimer’s Disease

Top tips for informed conversations with patients and their families around this new class of drugs for Alzheimer’s disease (AD). Credit available for this activity expires: 10/28/25 Earn Credit / Learning Objectives & Disclosures: ...

Published 10/29/24